Inhibition of monoamine oxidases by coumarin-3-acyl derivatives: biological activity and computational study

被引：97
作者：
Chimenti, F
Secci, D
Bolasco, A
Chimenti, P
Granese, A
Befani, O
Turini, P
Alcaro, S
Ortuso, F
机构：
[1] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Sostanze Biol Camente, I-00185 Rome, Italy
[2] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy
[3] Univ Roma La Sapienza, CNR, Ctr Biol Mol, I-00185 Rome, Italy
[4] Univ Catanzaro, Dipartimento Sci Farmaco Biol Complesso Nint Barb, I-88021 Roccelletta Di Borgia, CZ, Italy
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 14期
关键词：
MAO-inhibitors; coumarin;
D O I：
10.1016/j.bmcl.2004.05.010
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of coumarin-3-acyl derivatives have been synthesized and investigated for the ability to inhibit selectively monoamine oxidases. The coumarin-3-carboxylic acids, 2a-e, proved to be reversible and selective inhibitors of the MAO-B isoform, displaying pIC(50) values of particular interest: 2a shows pIC(50) 7.76 and a selectivity index (pS.I.) 2.94 and 2b shows pIC(50) 7.72 and a pS.I. of 2.80. The coumarin-3-acyl chlorides 3a-e showed high pIC(50) values against both MAO-A and MAO-B isoforms, 3d being the highest against MAO-B with a pIC(50) value of 8.00. In order to rationalize the activity/selectivity results, molecular descriptors were generated. Further insight about enzyme-inhibitor interaction was obtained by docking experiments with the MAO-B isoform. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3697 / 3703
页数：7
相关论文
共 41 条
[1]  
Alcaro S, 2000, J COMPUT CHEM, V21, P515, DOI 10.1002/(SICI)1096-987X(200005)21:7<515::AID-JCC2>3.0.CO
[2]  
2-5
[3]   MONOAMINE-OXIDASE INHIBITORS AND THE CHEESE EFFECT [J].
ANDERSON, MC ;
HASAN, F ;
MCCRODDEN, JM ;
TIPTON, KF .
NEUROCHEMICAL RESEARCH, 1993, 18 (11) :1145-1149
[4]  
Basford R. E., 1967, METHOD ENZYMOL, V10, P96
[5]   MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: In vivo studies with positron emission tomography [J].
Bergstrom, M ;
Westerberg, G ;
Nemeth, G ;
Traut, M ;
Gross, G ;
Greger, G ;
MullerPeltzer, H ;
Safer, A ;
Eckernas, SA ;
Grahner, A ;
Langstrom, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (02) :121-128
[6]   Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders [J].
Binda, C ;
Newton-Vinson, P ;
Hubálek, F ;
Edmondson, DE ;
Mattevi, A .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (01) :22-26
[7]   Synthesis of coumarin-3-O-acylisoureas by different carbodiimides [J].
Bonsignore, L ;
Cottiglia, F ;
Lavagna, SM ;
Loy, G ;
Secci, D .
HETEROCYCLES, 1999, 50 (01) :469-478
[8]   Synthesis via carbon suboxide and pharmacological activity of coumarin derivatives [J].
Bonsignore, L ;
Cottiglia, F ;
Lavagna, SM ;
Loy, G ;
Secci, D .
FARMACO, 1998, 53 (10-11) :693-697
[9]   SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF COUMARIN AND BENZODIOXAZEPINE-SUBSTITUTED, DIAZAZEPINE-SUBSTITUTED AND BENZOXAZEPINE-SUBSTITUTED PENICILLINS [J].
BONSIGNORE, L ;
DELOGU, A ;
LOY, G ;
LAVAGNA, SM ;
SECCI, D .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1994, 29 (06) :479-485
[10]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
12345